nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP1A2—Estropipate—osteoporosis	0.0983	0.161	CbGbCtD
Bupivacaine—CYP2C19—Cholecalciferol—osteoporosis	0.0549	0.0899	CbGbCtD
Bupivacaine—CYP3A4—Estropipate—osteoporosis	0.0515	0.0844	CbGbCtD
Bupivacaine—CYP3A4—Calcitriol—osteoporosis	0.0515	0.0844	CbGbCtD
Bupivacaine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0465	0.0762	CbGbCtD
Bupivacaine—CYP2C19—Estradiol—osteoporosis	0.0442	0.0725	CbGbCtD
Bupivacaine—CYP2D6—Cholecalciferol—osteoporosis	0.0417	0.0683	CbGbCtD
Bupivacaine—CYP3A4—Ergocalciferol—osteoporosis	0.0412	0.0674	CbGbCtD
Bupivacaine—CYP1A2—Estradiol—osteoporosis	0.0408	0.0669	CbGbCtD
Bupivacaine—CYP3A4—Raloxifene—osteoporosis	0.0344	0.0563	CbGbCtD
Bupivacaine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0332	0.0544	CbGbCtD
Bupivacaine—CYP3A4—Cholecalciferol—osteoporosis	0.0265	0.0435	CbGbCtD
Bupivacaine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0244	0.0399	CbGbCtD
Bupivacaine—CYP3A4—Estradiol—osteoporosis	0.0214	0.035	CbGbCtD
Bupivacaine—Urticaria—Ibandronate—osteoporosis	0.000331	0.0009	CcSEcCtD
Bupivacaine—Abdominal pain—Ibandronate—osteoporosis	0.000329	0.000896	CcSEcCtD
Bupivacaine—Body temperature increased—Ibandronate—osteoporosis	0.000329	0.000896	CcSEcCtD
Bupivacaine—Confusional state—Pamidronate—osteoporosis	0.000329	0.000895	CcSEcCtD
Bupivacaine—Syncope—Zoledronate—osteoporosis	0.000327	0.000891	CcSEcCtD
Bupivacaine—Anaphylactic shock—Pamidronate—osteoporosis	0.000326	0.000888	CcSEcCtD
Bupivacaine—Oedema—Pamidronate—osteoporosis	0.000326	0.000888	CcSEcCtD
Bupivacaine—Infection—Pamidronate—osteoporosis	0.000324	0.000882	CcSEcCtD
Bupivacaine—Urticaria—Calcitriol—osteoporosis	0.000324	0.000881	CcSEcCtD
Bupivacaine—Palpitations—Zoledronate—osteoporosis	0.000323	0.000878	CcSEcCtD
Bupivacaine—Abdominal pain—Calcitriol—osteoporosis	0.000322	0.000877	CcSEcCtD
Bupivacaine—Body temperature increased—Calcitriol—osteoporosis	0.000322	0.000877	CcSEcCtD
Bupivacaine—Hypoaesthesia—Estradiol—osteoporosis	0.000321	0.000875	CcSEcCtD
Bupivacaine—Angioedema—Conjugated Estrogens—osteoporosis	0.000321	0.000874	CcSEcCtD
Bupivacaine—Shock—Pamidronate—osteoporosis	0.000321	0.000873	CcSEcCtD
Bupivacaine—Loss of consciousness—Zoledronate—osteoporosis	0.000321	0.000873	CcSEcCtD
Bupivacaine—Hypersensitivity—Estropipate—osteoporosis	0.00032	0.000871	CcSEcCtD
Bupivacaine—Nervous system disorder—Pamidronate—osteoporosis	0.00032	0.000871	CcSEcCtD
Bupivacaine—Vomiting—Etidronic acid—osteoporosis	0.000319	0.000868	CcSEcCtD
Bupivacaine—Cough—Zoledronate—osteoporosis	0.000318	0.000867	CcSEcCtD
Bupivacaine—Oedema peripheral—Estradiol—osteoporosis	0.000318	0.000867	CcSEcCtD
Bupivacaine—Tachycardia—Pamidronate—osteoporosis	0.000318	0.000866	CcSEcCtD
Bupivacaine—Convulsion—Zoledronate—osteoporosis	0.000316	0.000861	CcSEcCtD
Bupivacaine—Hyperhidrosis—Pamidronate—osteoporosis	0.000315	0.000858	CcSEcCtD
Bupivacaine—Syncope—Conjugated Estrogens—osteoporosis	0.000315	0.000858	CcSEcCtD
Bupivacaine—Hypertension—Zoledronate—osteoporosis	0.000315	0.000858	CcSEcCtD
Bupivacaine—Hypersensitivity—Alendronate—osteoporosis	0.000315	0.000858	CcSEcCtD
Bupivacaine—Headache—Etidronic acid—osteoporosis	0.000314	0.000856	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000313	0.000851	CcSEcCtD
Bupivacaine—Asthenia—Estropipate—osteoporosis	0.000311	0.000848	CcSEcCtD
Bupivacaine—Arthralgia—Zoledronate—osteoporosis	0.000311	0.000846	CcSEcCtD
Bupivacaine—Palpitations—Conjugated Estrogens—osteoporosis	0.000311	0.000845	CcSEcCtD
Bupivacaine—Insomnia—Risedronate—osteoporosis	0.00031	0.000845	CcSEcCtD
Bupivacaine—Anxiety—Zoledronate—osteoporosis	0.00031	0.000843	CcSEcCtD
Bupivacaine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000309	0.000841	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000309	0.00084	CcSEcCtD
Bupivacaine—Paraesthesia—Risedronate—osteoporosis	0.000308	0.000839	CcSEcCtD
Bupivacaine—Pruritus—Estropipate—osteoporosis	0.000307	0.000836	CcSEcCtD
Bupivacaine—Asthenia—Alendronate—osteoporosis	0.000307	0.000835	CcSEcCtD
Bupivacaine—Hypersensitivity—Ibandronate—osteoporosis	0.000307	0.000835	CcSEcCtD
Bupivacaine—Cough—Conjugated Estrogens—osteoporosis	0.000307	0.000835	CcSEcCtD
Bupivacaine—Dyspnoea—Risedronate—osteoporosis	0.000306	0.000833	CcSEcCtD
Bupivacaine—Hypotension—Pamidronate—osteoporosis	0.000305	0.00083	CcSEcCtD
Bupivacaine—Convulsion—Conjugated Estrogens—osteoporosis	0.000304	0.000829	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000304	0.000827	CcSEcCtD
Bupivacaine—Pruritus—Alendronate—osteoporosis	0.000302	0.000823	CcSEcCtD
Bupivacaine—Dyspepsia—Risedronate—osteoporosis	0.000302	0.000822	CcSEcCtD
Bupivacaine—Tinnitus—Estradiol—osteoporosis	0.000301	0.00082	CcSEcCtD
Bupivacaine—Constipation—Ethinyl Estradiol—osteoporosis	0.000301	0.000819	CcSEcCtD
Bupivacaine—Confusional state—Zoledronate—osteoporosis	0.0003	0.000818	CcSEcCtD
Bupivacaine—Hypersensitivity—Calcitriol—osteoporosis	0.0003	0.000817	CcSEcCtD
Bupivacaine—Flushing—Estradiol—osteoporosis	0.0003	0.000816	CcSEcCtD
Bupivacaine—Cardiac disorder—Estradiol—osteoporosis	0.0003	0.000816	CcSEcCtD
Bupivacaine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000299	0.000815	CcSEcCtD
Bupivacaine—Asthenia—Ibandronate—osteoporosis	0.000299	0.000813	CcSEcCtD
Bupivacaine—Anxiety—Conjugated Estrogens—osteoporosis	0.000298	0.000812	CcSEcCtD
Bupivacaine—Nausea—Etidronic acid—osteoporosis	0.000298	0.000811	CcSEcCtD
Bupivacaine—Oedema—Zoledronate—osteoporosis	0.000298	0.000811	CcSEcCtD
Bupivacaine—Anaphylactic shock—Zoledronate—osteoporosis	0.000298	0.000811	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000297	0.000809	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000297	0.000809	CcSEcCtD
Bupivacaine—Diarrhoea—Estropipate—osteoporosis	0.000297	0.000809	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000296	0.000806	CcSEcCtD
Bupivacaine—Infection—Zoledronate—osteoporosis	0.000296	0.000806	CcSEcCtD
Bupivacaine—Insomnia—Pamidronate—osteoporosis	0.000295	0.000803	CcSEcCtD
Bupivacaine—Pruritus—Ibandronate—osteoporosis	0.000294	0.000802	CcSEcCtD
Bupivacaine—Pain—Risedronate—osteoporosis	0.000293	0.000799	CcSEcCtD
Bupivacaine—Constipation—Risedronate—osteoporosis	0.000293	0.000799	CcSEcCtD
Bupivacaine—Shock—Zoledronate—osteoporosis	0.000293	0.000798	CcSEcCtD
Bupivacaine—Paraesthesia—Pamidronate—osteoporosis	0.000293	0.000797	CcSEcCtD
Bupivacaine—Diarrhoea—Alendronate—osteoporosis	0.000293	0.000796	CcSEcCtD
Bupivacaine—Asthenia—Calcitriol—osteoporosis	0.000292	0.000796	CcSEcCtD
Bupivacaine—Nervous system disorder—Zoledronate—osteoporosis	0.000292	0.000795	CcSEcCtD
Bupivacaine—Dyspnoea—Pamidronate—osteoporosis	0.000291	0.000791	CcSEcCtD
Bupivacaine—Tachycardia—Zoledronate—osteoporosis	0.000291	0.000791	CcSEcCtD
Bupivacaine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00029	0.000789	CcSEcCtD
Bupivacaine—Chills—Estradiol—osteoporosis	0.00029	0.000789	CcSEcCtD
Bupivacaine—Somnolence—Pamidronate—osteoporosis	0.00029	0.000789	CcSEcCtD
Bupivacaine—Skin disorder—Zoledronate—osteoporosis	0.000289	0.000788	CcSEcCtD
Bupivacaine—Pruritus—Calcitriol—osteoporosis	0.000288	0.000785	CcSEcCtD
Bupivacaine—Hyperhidrosis—Zoledronate—osteoporosis	0.000288	0.000784	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000288	0.000783	CcSEcCtD
Bupivacaine—Diarrhoea—Raloxifene—osteoporosis	0.000288	0.000783	CcSEcCtD
Bupivacaine—Dyspepsia—Pamidronate—osteoporosis	0.000287	0.000781	CcSEcCtD
Bupivacaine—Dizziness—Estropipate—osteoporosis	0.000287	0.000781	CcSEcCtD
Bupivacaine—Oedema—Conjugated Estrogens—osteoporosis	0.000287	0.000781	CcSEcCtD
Bupivacaine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000287	0.000781	CcSEcCtD
Bupivacaine—Infection—Conjugated Estrogens—osteoporosis	0.000285	0.000776	CcSEcCtD
Bupivacaine—Diarrhoea—Ibandronate—osteoporosis	0.000285	0.000775	CcSEcCtD
Bupivacaine—Decreased appetite—Pamidronate—osteoporosis	0.000283	0.000772	CcSEcCtD
Bupivacaine—Mental disorder—Estradiol—osteoporosis	0.000283	0.000771	CcSEcCtD
Bupivacaine—Dizziness—Alendronate—osteoporosis	0.000283	0.00077	CcSEcCtD
Bupivacaine—Shock—Conjugated Estrogens—osteoporosis	0.000282	0.000768	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000282	0.000766	CcSEcCtD
Bupivacaine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000281	0.000766	CcSEcCtD
Bupivacaine—Erythema—Estradiol—osteoporosis	0.000281	0.000766	CcSEcCtD
Bupivacaine—Malnutrition—Estradiol—osteoporosis	0.000281	0.000766	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Risedronate—osteoporosis	0.000281	0.000764	CcSEcCtD
Bupivacaine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00028	0.000762	CcSEcCtD
Bupivacaine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00028	0.000761	CcSEcCtD
Bupivacaine—Pain—Pamidronate—osteoporosis	0.000279	0.000759	CcSEcCtD
Bupivacaine—Constipation—Pamidronate—osteoporosis	0.000279	0.000759	CcSEcCtD
Bupivacaine—Diarrhoea—Calcitriol—osteoporosis	0.000279	0.000759	CcSEcCtD
Bupivacaine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000279	0.000758	CcSEcCtD
Bupivacaine—Hypotension—Zoledronate—osteoporosis	0.000278	0.000758	CcSEcCtD
Bupivacaine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000278	0.000757	CcSEcCtD
Bupivacaine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000278	0.000757	CcSEcCtD
Bupivacaine—Dizziness—Raloxifene—osteoporosis	0.000278	0.000757	CcSEcCtD
Bupivacaine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000277	0.000755	CcSEcCtD
Bupivacaine—Flatulence—Estradiol—osteoporosis	0.000277	0.000755	CcSEcCtD
Bupivacaine—Tension—Estradiol—osteoporosis	0.000276	0.000751	CcSEcCtD
Bupivacaine—Vomiting—Estropipate—osteoporosis	0.000276	0.000751	CcSEcCtD
Bupivacaine—Dizziness—Ibandronate—osteoporosis	0.000275	0.000749	CcSEcCtD
Bupivacaine—Nervousness—Estradiol—osteoporosis	0.000273	0.000744	CcSEcCtD
Bupivacaine—Urticaria—Risedronate—osteoporosis	0.000273	0.000742	CcSEcCtD
Bupivacaine—Back pain—Estradiol—osteoporosis	0.000272	0.000741	CcSEcCtD
Bupivacaine—Headache—Estropipate—osteoporosis	0.000272	0.00074	CcSEcCtD
Bupivacaine—Vomiting—Alendronate—osteoporosis	0.000272	0.00074	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000271	0.000739	CcSEcCtD
Bupivacaine—Abdominal pain—Risedronate—osteoporosis	0.000271	0.000738	CcSEcCtD
Bupivacaine—Body temperature increased—Risedronate—osteoporosis	0.000271	0.000738	CcSEcCtD
Bupivacaine—Muscle spasms—Estradiol—osteoporosis	0.00027	0.000736	CcSEcCtD
Bupivacaine—Insomnia—Zoledronate—osteoporosis	0.000269	0.000733	CcSEcCtD
Bupivacaine—Feeling abnormal—Pamidronate—osteoporosis	0.000269	0.000732	CcSEcCtD
Bupivacaine—Hypotension—Conjugated Estrogens—osteoporosis	0.000268	0.00073	CcSEcCtD
Bupivacaine—Headache—Alendronate—osteoporosis	0.000268	0.000729	CcSEcCtD
Bupivacaine—Paraesthesia—Zoledronate—osteoporosis	0.000267	0.000728	CcSEcCtD
Bupivacaine—Vomiting—Raloxifene—osteoporosis	0.000267	0.000728	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000267	0.000726	CcSEcCtD
Bupivacaine—Dyspnoea—Zoledronate—osteoporosis	0.000266	0.000723	CcSEcCtD
Bupivacaine—Somnolence—Zoledronate—osteoporosis	0.000265	0.000721	CcSEcCtD
Bupivacaine—Vomiting—Ibandronate—osteoporosis	0.000265	0.000721	CcSEcCtD
Bupivacaine—Tremor—Estradiol—osteoporosis	0.000264	0.000717	CcSEcCtD
Bupivacaine—Headache—Raloxifene—osteoporosis	0.000263	0.000717	CcSEcCtD
Bupivacaine—Dyspepsia—Zoledronate—osteoporosis	0.000262	0.000714	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000261	0.000711	CcSEcCtD
Bupivacaine—Headache—Ibandronate—osteoporosis	0.000261	0.00071	CcSEcCtD
Bupivacaine—Insomnia—Conjugated Estrogens—osteoporosis	0.000259	0.000706	CcSEcCtD
Bupivacaine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000259	0.000706	CcSEcCtD
Bupivacaine—Vomiting—Calcitriol—osteoporosis	0.000259	0.000705	CcSEcCtD
Bupivacaine—Decreased appetite—Zoledronate—osteoporosis	0.000259	0.000705	CcSEcCtD
Bupivacaine—Agitation—Estradiol—osteoporosis	0.000258	0.000704	CcSEcCtD
Bupivacaine—Nausea—Estropipate—osteoporosis	0.000258	0.000702	CcSEcCtD
Bupivacaine—Abdominal pain—Pamidronate—osteoporosis	0.000258	0.000702	CcSEcCtD
Bupivacaine—Body temperature increased—Pamidronate—osteoporosis	0.000258	0.000702	CcSEcCtD
Bupivacaine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000258	0.000701	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000257	0.0007	CcSEcCtD
Bupivacaine—Angioedema—Estradiol—osteoporosis	0.000257	0.0007	CcSEcCtD
Bupivacaine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000256	0.000696	CcSEcCtD
Bupivacaine—Headache—Calcitriol—osteoporosis	0.000255	0.000695	CcSEcCtD
Bupivacaine—Somnolence—Conjugated Estrogens—osteoporosis	0.000255	0.000694	CcSEcCtD
Bupivacaine—Pain—Zoledronate—osteoporosis	0.000255	0.000693	CcSEcCtD
Bupivacaine—Constipation—Zoledronate—osteoporosis	0.000255	0.000693	CcSEcCtD
Bupivacaine—Nausea—Alendronate—osteoporosis	0.000254	0.000691	CcSEcCtD
Bupivacaine—Hypersensitivity—Risedronate—osteoporosis	0.000253	0.000688	CcSEcCtD
Bupivacaine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000252	0.000687	CcSEcCtD
Bupivacaine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000252	0.000687	CcSEcCtD
Bupivacaine—Syncope—Estradiol—osteoporosis	0.000252	0.000687	CcSEcCtD
Bupivacaine—Nausea—Raloxifene—osteoporosis	0.00025	0.00068	CcSEcCtD
Bupivacaine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000249	0.000679	CcSEcCtD
Bupivacaine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000249	0.000678	CcSEcCtD
Bupivacaine—Palpitations—Estradiol—osteoporosis	0.000249	0.000677	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000248	0.000674	CcSEcCtD
Bupivacaine—Nausea—Ibandronate—osteoporosis	0.000247	0.000673	CcSEcCtD
Bupivacaine—Loss of consciousness—Estradiol—osteoporosis	0.000247	0.000673	CcSEcCtD
Bupivacaine—Asthenia—Risedronate—osteoporosis	0.000246	0.00067	CcSEcCtD
Bupivacaine—Feeling abnormal—Zoledronate—osteoporosis	0.000245	0.000668	CcSEcCtD
Bupivacaine—Cough—Estradiol—osteoporosis	0.000245	0.000668	CcSEcCtD
Bupivacaine—Constipation—Conjugated Estrogens—osteoporosis	0.000245	0.000668	CcSEcCtD
Bupivacaine—Pain—Conjugated Estrogens—osteoporosis	0.000245	0.000668	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000244	0.000663	CcSEcCtD
Bupivacaine—Hypertension—Estradiol—osteoporosis	0.000243	0.000661	CcSEcCtD
Bupivacaine—Pruritus—Risedronate—osteoporosis	0.000243	0.000661	CcSEcCtD
Bupivacaine—Nausea—Calcitriol—osteoporosis	0.000242	0.000659	CcSEcCtD
Bupivacaine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000241	0.000655	CcSEcCtD
Bupivacaine—Hypersensitivity—Pamidronate—osteoporosis	0.00024	0.000654	CcSEcCtD
Bupivacaine—Arthralgia—Estradiol—osteoporosis	0.000239	0.000652	CcSEcCtD
Bupivacaine—Anxiety—Estradiol—osteoporosis	0.000239	0.00065	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000238	0.000647	CcSEcCtD
Bupivacaine—Urticaria—Zoledronate—osteoporosis	0.000237	0.000644	CcSEcCtD
Bupivacaine—Abdominal pain—Zoledronate—osteoporosis	0.000235	0.000641	CcSEcCtD
Bupivacaine—Body temperature increased—Zoledronate—osteoporosis	0.000235	0.000641	CcSEcCtD
Bupivacaine—Diarrhoea—Risedronate—osteoporosis	0.000235	0.000639	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000235	0.000639	CcSEcCtD
Bupivacaine—Asthenia—Pamidronate—osteoporosis	0.000234	0.000637	CcSEcCtD
Bupivacaine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000233	0.000633	CcSEcCtD
Bupivacaine—Confusional state—Estradiol—osteoporosis	0.000231	0.00063	CcSEcCtD
Bupivacaine—Pruritus—Pamidronate—osteoporosis	0.000231	0.000628	CcSEcCtD
Bupivacaine—Anaphylactic shock—Estradiol—osteoporosis	0.00023	0.000625	CcSEcCtD
Bupivacaine—Oedema—Estradiol—osteoporosis	0.00023	0.000625	CcSEcCtD
Bupivacaine—Infection—Estradiol—osteoporosis	0.000228	0.000621	CcSEcCtD
Bupivacaine—Urticaria—Conjugated Estrogens—osteoporosis	0.000228	0.00062	CcSEcCtD
Bupivacaine—Dizziness—Risedronate—osteoporosis	0.000227	0.000618	CcSEcCtD
Bupivacaine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000227	0.000617	CcSEcCtD
Bupivacaine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000227	0.000617	CcSEcCtD
Bupivacaine—Shock—Estradiol—osteoporosis	0.000226	0.000615	CcSEcCtD
Bupivacaine—Nervous system disorder—Estradiol—osteoporosis	0.000225	0.000613	CcSEcCtD
Bupivacaine—Tachycardia—Estradiol—osteoporosis	0.000224	0.00061	CcSEcCtD
Bupivacaine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000224	0.000609	CcSEcCtD
Bupivacaine—Diarrhoea—Pamidronate—osteoporosis	0.000223	0.000607	CcSEcCtD
Bupivacaine—Skin disorder—Estradiol—osteoporosis	0.000223	0.000607	CcSEcCtD
Bupivacaine—Hyperhidrosis—Estradiol—osteoporosis	0.000222	0.000604	CcSEcCtD
Bupivacaine—Headache—Ethinyl Estradiol—osteoporosis	0.00022	0.0006	CcSEcCtD
Bupivacaine—Hypersensitivity—Zoledronate—osteoporosis	0.000219	0.000597	CcSEcCtD
Bupivacaine—Vomiting—Risedronate—osteoporosis	0.000218	0.000594	CcSEcCtD
Bupivacaine—Dizziness—Pamidronate—osteoporosis	0.000216	0.000587	CcSEcCtD
Bupivacaine—Headache—Risedronate—osteoporosis	0.000215	0.000585	CcSEcCtD
Bupivacaine—Asthenia—Zoledronate—osteoporosis	0.000214	0.000582	CcSEcCtD
Bupivacaine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000211	0.000575	CcSEcCtD
Bupivacaine—Pruritus—Zoledronate—osteoporosis	0.000211	0.000574	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000209	0.000569	CcSEcCtD
Bupivacaine—Nausea—Ethinyl Estradiol—osteoporosis	0.000209	0.000569	CcSEcCtD
Bupivacaine—Insomnia—Estradiol—osteoporosis	0.000208	0.000565	CcSEcCtD
Bupivacaine—Vomiting—Pamidronate—osteoporosis	0.000207	0.000564	CcSEcCtD
Bupivacaine—Paraesthesia—Estradiol—osteoporosis	0.000206	0.000561	CcSEcCtD
Bupivacaine—Asthenia—Conjugated Estrogens—osteoporosis	0.000206	0.00056	CcSEcCtD
Bupivacaine—Dyspnoea—Estradiol—osteoporosis	0.000205	0.000557	CcSEcCtD
Bupivacaine—Headache—Pamidronate—osteoporosis	0.000204	0.000556	CcSEcCtD
Bupivacaine—Somnolence—Estradiol—osteoporosis	0.000204	0.000556	CcSEcCtD
Bupivacaine—Diarrhoea—Zoledronate—osteoporosis	0.000204	0.000555	CcSEcCtD
Bupivacaine—Nausea—Risedronate—osteoporosis	0.000204	0.000555	CcSEcCtD
Bupivacaine—Pruritus—Conjugated Estrogens—osteoporosis	0.000203	0.000552	CcSEcCtD
Bupivacaine—Dyspepsia—Estradiol—osteoporosis	0.000202	0.00055	CcSEcCtD
Bupivacaine—Decreased appetite—Estradiol—osteoporosis	0.0002	0.000543	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000198	0.00054	CcSEcCtD
Bupivacaine—Dizziness—Zoledronate—osteoporosis	0.000197	0.000536	CcSEcCtD
Bupivacaine—Pain—Estradiol—osteoporosis	0.000196	0.000534	CcSEcCtD
Bupivacaine—Constipation—Estradiol—osteoporosis	0.000196	0.000534	CcSEcCtD
Bupivacaine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000196	0.000534	CcSEcCtD
Bupivacaine—Nausea—Pamidronate—osteoporosis	0.000194	0.000527	CcSEcCtD
Bupivacaine—Dizziness—Conjugated Estrogens—osteoporosis	0.00019	0.000516	CcSEcCtD
Bupivacaine—Vomiting—Zoledronate—osteoporosis	0.000189	0.000516	CcSEcCtD
Bupivacaine—Feeling abnormal—Estradiol—osteoporosis	0.000189	0.000515	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Estradiol—osteoporosis	0.000188	0.000511	CcSEcCtD
Bupivacaine—Headache—Zoledronate—osteoporosis	0.000187	0.000508	CcSEcCtD
Bupivacaine—Vomiting—Conjugated Estrogens—osteoporosis	0.000182	0.000496	CcSEcCtD
Bupivacaine—Urticaria—Estradiol—osteoporosis	0.000182	0.000496	CcSEcCtD
Bupivacaine—Body temperature increased—Estradiol—osteoporosis	0.000181	0.000494	CcSEcCtD
Bupivacaine—Abdominal pain—Estradiol—osteoporosis	0.000181	0.000494	CcSEcCtD
Bupivacaine—Headache—Conjugated Estrogens—osteoporosis	0.00018	0.000489	CcSEcCtD
Bupivacaine—Nausea—Zoledronate—osteoporosis	0.000177	0.000482	CcSEcCtD
Bupivacaine—Nausea—Conjugated Estrogens—osteoporosis	0.00017	0.000464	CcSEcCtD
Bupivacaine—Hypersensitivity—Estradiol—osteoporosis	0.000169	0.00046	CcSEcCtD
Bupivacaine—Asthenia—Estradiol—osteoporosis	0.000165	0.000448	CcSEcCtD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000163	0.00737	CbGpPWpGaD
Bupivacaine—Pruritus—Estradiol—osteoporosis	0.000162	0.000442	CcSEcCtD
Bupivacaine—Diarrhoea—Estradiol—osteoporosis	0.000157	0.000428	CcSEcCtD
Bupivacaine—Dizziness—Estradiol—osteoporosis	0.000152	0.000413	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—PTH—osteoporosis	0.000152	0.00686	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTH1R—osteoporosis	0.000148	0.0067	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CALCR—osteoporosis	0.000148	0.0067	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CNR2—osteoporosis	0.000148	0.00669	CbGpPWpGaD
Bupivacaine—Vomiting—Estradiol—osteoporosis	0.000146	0.000397	CcSEcCtD
Bupivacaine—Headache—Estradiol—osteoporosis	0.000144	0.000391	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—WNT1—osteoporosis	0.000139	0.00629	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000138	0.00625	CbGpPWpGaD
Bupivacaine—Nausea—Estradiol—osteoporosis	0.000136	0.000371	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—WNT1—osteoporosis	0.000134	0.00605	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000131	0.00595	CbGpPWpGaD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00013	0.00587	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—MGLL—osteoporosis	0.00013	0.00587	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—WNT1—osteoporosis	0.000129	0.00583	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTHLH—osteoporosis	0.000126	0.00569	CbGpPWpGaD
Bupivacaine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000124	0.0056	CbGpPWpGaD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000123	0.00557	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—MGLL—osteoporosis	0.000118	0.00533	CbGpPWpGaD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000115	0.0052	CbGpPWpGaD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000113	0.00513	CbGpPWpGaD
Bupivacaine—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	0.000111	0.00501	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CALCA—osteoporosis	0.000111	0.00501	CbGpPWpGaD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	0.000108	0.00489	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000107	0.00482	CbGpPWpGaD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000106	0.00478	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000104	0.00472	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.0001	0.00453	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SOST—osteoporosis	9.68e-05	0.00438	CbGpPWpGaD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	9.5e-05	0.0043	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	9.41e-05	0.00426	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	9.31e-05	0.00421	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	9.28e-05	0.0042	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.94e-05	0.00405	CbGpPWpGaD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.83e-05	0.004	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CALCR—osteoporosis	8.75e-05	0.00396	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTH1R—osteoporosis	8.75e-05	0.00396	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	8.66e-05	0.00392	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PTH—osteoporosis	8.57e-05	0.00388	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.56e-05	0.00387	CbGpPWpGaD
Bupivacaine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	8.54e-05	0.00386	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	8.54e-05	0.00386	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	8.43e-05	0.00381	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CNR2—osteoporosis	8.35e-05	0.00378	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTH—osteoporosis	7.78e-05	0.00352	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6R—osteoporosis	7.61e-05	0.00344	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.6e-05	0.00344	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CNR2—osteoporosis	7.58e-05	0.00343	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	7.39e-05	0.00334	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6R—osteoporosis	7.34e-05	0.00332	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	7.33e-05	0.00332	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.25e-05	0.00328	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	7.23e-05	0.00327	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—WNT1—osteoporosis	7.13e-05	0.00323	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PTHLH—osteoporosis	7.1e-05	0.00321	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MGLL—osteoporosis	6.95e-05	0.00315	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.9e-05	0.00312	CbGpPWpGaD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.9e-05	0.00312	CbGpPWpGaD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.81e-05	0.00308	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LRP5—osteoporosis	6.79e-05	0.00307	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LRP6—osteoporosis	6.49e-05	0.00294	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—LEP—osteoporosis	6.48e-05	0.00293	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PTHLH—osteoporosis	6.45e-05	0.00292	CbGpPWpGaD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.35e-05	0.00287	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	6.29e-05	0.00285	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CALCA—osteoporosis	6.25e-05	0.00283	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—LEP—osteoporosis	6.25e-05	0.00283	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.96e-05	0.0027	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—POMC—osteoporosis	5.79e-05	0.00262	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CALCA—osteoporosis	5.68e-05	0.00257	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	5.66e-05	0.00256	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.6e-05	0.00253	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.59e-05	0.00253	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.58e-05	0.00253	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TLN1—osteoporosis	5.48e-05	0.00248	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6R—osteoporosis	5.43e-05	0.00246	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.38e-05	0.00243	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6R—osteoporosis	5.23e-05	0.00237	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.14e-05	0.00233	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	4.94e-05	0.00224	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	4.93e-05	0.00223	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.9e-05	0.00222	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	4.88e-05	0.00221	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—P4HB—osteoporosis	4.73e-05	0.00214	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.65e-05	0.0021	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.64e-05	0.0021	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTH—osteoporosis	4.6e-05	0.00208	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	4.55e-05	0.00206	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.52e-05	0.00205	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RAP1A—osteoporosis	4.52e-05	0.00204	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	4.48e-05	0.00203	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CNR2—osteoporosis	4.48e-05	0.00203	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.46e-05	0.00202	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—ADCY5—osteoporosis	4.45e-05	0.00201	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NFATC1—osteoporosis	4.41e-05	0.00199	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—DKK1—osteoporosis	4.37e-05	0.00198	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.36e-05	0.00197	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—WNT1—osteoporosis	4.21e-05	0.00191	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.15e-05	0.00188	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGA—osteoporosis	4.1e-05	0.00185	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ADCY5—osteoporosis	4.04e-05	0.00183	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	3.85e-05	0.00174	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	3.84e-05	0.00174	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	3.83e-05	0.00174	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—BMP2—osteoporosis	3.81e-05	0.00172	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTHLH—osteoporosis	3.81e-05	0.00172	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	3.8e-05	0.00172	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGB—osteoporosis	3.73e-05	0.00169	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.61e-05	0.00164	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.61e-05	0.00164	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PSMA2—osteoporosis	3.6e-05	0.00163	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PSMA5—osteoporosis	3.6e-05	0.00163	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	3.58e-05	0.00162	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	3.58e-05	0.00162	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.52e-05	0.00159	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6—osteoporosis	3.39e-05	0.00153	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.36e-05	0.00152	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CALCA—osteoporosis	3.35e-05	0.00152	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—POMC—osteoporosis	3.27e-05	0.00148	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6—osteoporosis	3.27e-05	0.00148	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TGFB1—osteoporosis	3.21e-05	0.00145	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TGFB1—osteoporosis	3.09e-05	0.0014	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.07e-05	0.00139	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KL—osteoporosis	3.05e-05	0.00138	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—osteoporosis	3e-05	0.00136	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.97e-05	0.00135	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—POMC—osteoporosis	2.97e-05	0.00134	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—POMC—osteoporosis	2.97e-05	0.00134	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.93e-05	0.00133	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6R—osteoporosis	2.9e-05	0.00131	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—osteoporosis	2.89e-05	0.00131	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.82e-05	0.00127	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PKM—osteoporosis	2.8e-05	0.00127	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—FDPS—osteoporosis	2.8e-05	0.00127	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—POMC—osteoporosis	2.73e-05	0.00124	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPD2—osteoporosis	2.66e-05	0.0012	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PGLS—osteoporosis	2.66e-05	0.0012	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—FDPS—osteoporosis	2.58e-05	0.00117	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PKM—osteoporosis	2.58e-05	0.00117	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPD2—osteoporosis	2.44e-05	0.00111	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PGLS—osteoporosis	2.44e-05	0.00111	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PNP—osteoporosis	2.43e-05	0.0011	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ATIC—osteoporosis	2.43e-05	0.0011	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6—osteoporosis	2.42e-05	0.00109	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.39e-05	0.00108	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ADCY5—osteoporosis	2.39e-05	0.00108	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6—osteoporosis	2.33e-05	0.00106	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—POMC—osteoporosis	2.31e-05	0.00105	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SPP1—osteoporosis	2.31e-05	0.00104	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ATIC—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PNP—osteoporosis	2.23e-05	0.00101	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PKM—osteoporosis	2.18e-05	0.000988	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—FDPS—osteoporosis	2.18e-05	0.000988	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IRS2—osteoporosis	2.09e-05	0.000945	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPD2—osteoporosis	2.07e-05	0.000937	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PGLS—osteoporosis	2.07e-05	0.000937	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA2—osteoporosis	2.07e-05	0.000935	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—OXCT1—osteoporosis	2.07e-05	0.000935	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LEP—osteoporosis	2.04e-05	0.000924	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MGLL—osteoporosis	2.01e-05	0.000911	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ESR1—osteoporosis	1.95e-05	0.000883	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA2—osteoporosis	1.9e-05	0.00086	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—OXCT1—osteoporosis	1.9e-05	0.00086	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.9e-05	0.000859	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PNP—osteoporosis	1.89e-05	0.000857	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ATIC—osteoporosis	1.89e-05	0.000857	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MGLL—osteoporosis	1.85e-05	0.000838	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IRS1—osteoporosis	1.82e-05	0.000825	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.79e-05	0.000809	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—POMC—osteoporosis	1.75e-05	0.000794	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—IDH2—osteoporosis	1.71e-05	0.000775	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6R—osteoporosis	1.71e-05	0.000775	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF1—osteoporosis	1.69e-05	0.000764	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PKM—osteoporosis	1.68e-05	0.000763	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—FDPS—osteoporosis	1.68e-05	0.000763	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA2—osteoporosis	1.61e-05	0.000728	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—OXCT1—osteoporosis	1.61e-05	0.000728	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.61e-05	0.000728	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PGLS—osteoporosis	1.6e-05	0.000723	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPD2—osteoporosis	1.6e-05	0.000723	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—IDH2—osteoporosis	1.57e-05	0.000713	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MGLL—osteoporosis	1.57e-05	0.00071	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ACP5—osteoporosis	1.57e-05	0.000709	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.55e-05	0.0007	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.48e-05	0.00067	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.48e-05	0.000669	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PNP—osteoporosis	1.46e-05	0.000661	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ATIC—osteoporosis	1.46e-05	0.000661	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TPI1—osteoporosis	1.46e-05	0.000659	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ACP5—osteoporosis	1.44e-05	0.000652	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—P4HB—osteoporosis	1.37e-05	0.000619	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.34e-05	0.000608	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TPI1—osteoporosis	1.34e-05	0.000606	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—IDH2—osteoporosis	1.33e-05	0.000604	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.31e-05	0.000592	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—osteoporosis	1.29e-05	0.000584	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—P4HB—osteoporosis	1.26e-05	0.00057	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000568	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA2—osteoporosis	1.24e-05	0.000562	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.24e-05	0.000562	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.24e-05	0.000559	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ACP5—osteoporosis	1.22e-05	0.000552	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MGLL—osteoporosis	1.21e-05	0.000548	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.2e-05	0.000545	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.2e-05	0.000545	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.14e-05	0.000516	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TPI1—osteoporosis	1.13e-05	0.000513	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—P4HB—osteoporosis	1.07e-05	0.000483	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO1—osteoporosis	1.06e-05	0.000479	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000474	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMA2—osteoporosis	1.04e-05	0.000472	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMA5—osteoporosis	1.04e-05	0.000472	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—IDH2—osteoporosis	1.03e-05	0.000466	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—RAP1A—osteoporosis	1.02e-05	0.000461	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—osteoporosis	1.01e-05	0.000459	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	0.000458	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO1—osteoporosis	9.73e-06	0.00044	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.68e-06	0.000438	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMA2—osteoporosis	9.58e-06	0.000434	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMA5—osteoporosis	9.58e-06	0.000434	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ACP5—osteoporosis	9.41e-06	0.000426	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.89e-06	0.000402	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TPI1—osteoporosis	8.75e-06	0.000396	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.45e-06	0.000383	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO1—osteoporosis	8.24e-06	0.000373	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—P4HB—osteoporosis	8.23e-06	0.000372	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMA2—osteoporosis	8.12e-06	0.000367	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMA5—osteoporosis	8.12e-06	0.000367	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GAPDH—osteoporosis	8.08e-06	0.000366	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—RAP1A—osteoporosis	7.87e-06	0.000356	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP19A1—osteoporosis	7.78e-06	0.000352	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—osteoporosis	7.62e-06	0.000345	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ADCY5—osteoporosis	6.91e-06	0.000313	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPX1—osteoporosis	6.88e-06	0.000312	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP19A1—osteoporosis	6.59e-06	0.000298	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO1—osteoporosis	6.36e-06	0.000288	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ADCY5—osteoporosis	6.35e-06	0.000288	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—osteoporosis	6.35e-06	0.000288	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPX1—osteoporosis	6.33e-06	0.000287	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMA5—osteoporosis	6.27e-06	0.000284	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMA2—osteoporosis	6.27e-06	0.000284	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.84e-06	0.000264	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ADCY5—osteoporosis	5.38e-06	0.000244	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX1—osteoporosis	5.36e-06	0.000243	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.08e-06	0.00023	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—POMC—osteoporosis	5.08e-06	0.00023	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—osteoporosis	4.95e-06	0.000224	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—POMC—osteoporosis	4.67e-06	0.000211	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ADCY5—osteoporosis	4.15e-06	0.000188	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX1—osteoporosis	4.14e-06	0.000187	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—POMC—osteoporosis	3.96e-06	0.000179	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.82e-06	0.000173	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—POMC—osteoporosis	3.06e-06	0.000138	CbGpPWpGaD
